Search details
1.
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study.
Oncologist
; 29(3): e372-e381, 2024 Mar 04.
Article
in English
| MEDLINE | ID: mdl-37796838
2.
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors.
Cancer Immunol Immunother
; 72(7): 2127-2135, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36828963
3.
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.
Oncologist
; 24(6): e327-e337, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30796151
4.
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
Eur J Cancer
; 202: 114006, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38489861
5.
Safety and Efficacy Outcomes of Early Cessation of Anti-PD1 Therapy in Patients 80 Years or Older: A Retrospective Cohort Study.
Cancer Lett
; : 217001, 2024 Jun 03.
Article
in English
| MEDLINE | ID: mdl-38838764
6.
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario.
Technol Cancer Res Treat
; 22: 15330338231159753, 2023.
Article
in English
| MEDLINE | ID: mdl-36855829
7.
Thirty-day mortality in hospitalised patients with lung cancer: incidence and predictors.
BMJ Support Palliat Care
; 2023 Sep 04.
Article
in English
| MEDLINE | ID: mdl-37666650
8.
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study.
EClinicalMedicine
; 61: 102044, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37434748
9.
Role of ctDNA for the detection of minimal residual disease in resected non-small cell lung cancer: a systematic review.
Transl Lung Cancer Res
; 11(12): 2588-2600, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36636413
10.
Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring BRAF Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E Subgroups.
Cancers (Basel)
; 14(8)2022 Apr 16.
Article
in English
| MEDLINE | ID: mdl-35454926
11.
Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP).
Lung Cancer
; 174: 118-124, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36379124
12.
Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study.
Clin Lung Cancer
; 23(7): e478-e488, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36002369
13.
First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysis.
Transl Lung Cancer Res
; 10(6): 2917-2936, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-34295688
14.
Differential diagnosis of COVID-19 at the chest computed tomography scan: A review with special focus on cancer patients.
World J Radiol
; 13(8): 243-257, 2021 Aug 28.
Article
in English
| MEDLINE | ID: mdl-34567434
15.
Review on radiological evolution of COVID-19 pneumonia using computed tomography.
World J Radiol
; 13(9): 294-306, 2021 Sep 28.
Article
in English
| MEDLINE | ID: mdl-34630915
16.
Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study.
Clin Med Insights Oncol
; 15: 11795549211043427, 2021.
Article
in English
| MEDLINE | ID: mdl-34526833
17.
Exploring the role of respiratory microbiome in lung cancer: A systematic review.
Crit Rev Oncol Hematol
; 164: 103404, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34214609
18.
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy.
Eur J Cancer
; 150: 224-231, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33934059
19.
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index.
Eur J Cancer
; 142: 18-28, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33212418
20.
Prognostic and predictive molecular biomarkers in metastatic renal cell carcinoma patients treated with immune checkpoint inhibitors: a systematic review.
Expert Rev Mol Diagn
; 20(2): 169-185, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31608727